AIDS and Behavior

, Volume 17, Supplement 2, pp 203–211 | Cite as

Planning for Success Predicts Virus Suppressed: Results of a Non-Controlled, Observational Study of Factors Associated with Viral Suppression Among HIV-Positive Persons Following Jail Release

  • Anne C. Spaulding
  • Lauren C. Messina
  • Bryan I. Kim
  • Koo-Whang Chung
  • Thomas Lincoln
  • Paul Teixeira
  • Ann K. Avery
  • Marc Cunningham
  • Matthew S. Stein
  • Divya Ahuja
  • Timothy P. Flanigan
Original Paper

Abstract

In the United States, jail frequently disrupts access to HIV care. EnhanceLink, a 10-site demonstration project promoting linkage to HIV primary care upon jail discharge, offered an opportunity to gauge how many releasees had favorable clinical outcomes. Individual level data were available on 1270 participants. Persons never discharged from the correctional environment were excluded. Multivariate logistic regression identified factors associated with viral suppression 6 months post discharge (6M-VL < 400). Among 1082 individuals eligible for follow-up evaluation, 25.7 % had 6M-VL < 400. 6M-VL < 400 was associated with case managers assessing whether help was needed for linkage to HIV-related medical services and clients keeping an appointment with a case manager. The adjusted odds ratio (aOR) of 6M-VL < 400 associated with attending a meeting with an HIV care provider within 30 days of release was 1.85. The results of this non-controlled, observational study support further development and rigorous evaluation of transitional care programs for HIV-positive jailed persons across the country.

Keywords

HIV Linkage to care Retention in care Inmate Jail 

Supplementary material

10461_2012_341_MOESM1_ESM.docx (150 kb)
Supplementary material 1 (DOCX 150 kb)

References

  1. 1.
    Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of, and releasees from, US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2006;4(11):e7558. doi:10.1371/journal.pone.0007558.CrossRefGoogle Scholar
  2. 2.
    Pai NP, Estes M, Moodie EE, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS ONE [Electronic Resource]. 2009;4(9).Google Scholar
  3. 3.
    Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.PubMedCrossRefGoogle Scholar
  4. 4.
    Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.PubMedCrossRefGoogle Scholar
  5. 5.
    El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.PubMedCrossRefGoogle Scholar
  6. 6.
    Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRefGoogle Scholar
  7. 7.
    Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. [Review]. Clin Infect Dis. 2011;52(6):793–800.PubMedCrossRefGoogle Scholar
  8. 8.
    National HIV/AIDS Strategy for the United States. July 2010. Available: http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf. Accessed 3 Dec 2010.
  9. 9.
    Draine J, Ahuja D, Altice FL, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77.PubMedCrossRefGoogle Scholar
  10. 10.
    Addiction Severity Index, Fifth Edition 1998. Available at http://www.tresearch.org/resources/instruments/ASI_5th_Ed.pdf. Last accessed 3 June 2008.
  11. 11.
    Ware JEJP, Kosinski MM, Keller SDP. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.PubMedCrossRefGoogle Scholar
  12. 12.
    McGahan PL, Griffin JA, Parente R, McLellan AT. Addiction Severity Index: Composite Score Manual. Available: http://www.tresearch.org/resources/compscores/CompositeManual.pdf. Accessed 19 Dec 2011.
  13. 13.
    McLellan AT, Luborsky L, O’Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: the Addiction Severity Index. J Nervous Mental Dis. 1980;168:26–33.CrossRefGoogle Scholar
  14. 14.
    Rikoon SH, Cacciola JS, Carise D, Alterman AI, McLellan AT. Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Subst Abuse Treat. 2006;31(1):17–24.PubMedCrossRefGoogle Scholar
  15. 15.
    Cacciola J, Pecoraro A, Alterman A. Development of ASI Psychiatric Severity Cut-Off Scores to identify co-occurring psychiatric disorders. Int J Mental Health Addict. 2008;6(1):77–92.CrossRefGoogle Scholar
  16. 16.
    Puskas C, Forrest J, Parashar S, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep. 2011;8(4):277–87.PubMedCrossRefGoogle Scholar
  17. 17.
    Connell RW. Gender and Power. Stanford CA: Stanford University Press; 1987.Google Scholar
  18. 18.
    Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26(1):40–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antiviral Ther. 2004;9(5):713–9.Google Scholar
  20. 20.
    Superak H, Spaulding A, Yang Z, et al. Cost and cost-effectiveness considerations for jail linkage services. Abstract 1902. CDC HIV Prevention Conference. Atlanta GA.Google Scholar
  21. 21.
    Wohl DA, Scheyett A, Golin CE, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav 2011;15(2):356–64.Google Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Anne C. Spaulding
    • 1
    • 2
  • Lauren C. Messina
    • 2
  • Bryan I. Kim
    • 2
  • Koo-Whang Chung
    • 2
  • Thomas Lincoln
    • 3
  • Paul Teixeira
    • 4
  • Ann K. Avery
    • 5
  • Marc Cunningham
    • 2
  • Matthew S. Stein
    • 2
  • Divya Ahuja
    • 6
  • Timothy P. Flanigan
    • 7
  1. 1.Division of Infectious DiseasesEmory University School of MedicineAtlantaUSA
  2. 2.Department of Epidemiology, Rollins School of Public HealthEmory University School of MedicineAtlantaUSA
  3. 3.Internal MedicineBaystate Medical Center and Tufts UniversitySpringfieldUSA
  4. 4.New York City Department of Health and Mental HygieneTransitional Health Care CoordinationNew YorkUSA
  5. 5.Infectious DiseasesMetroHealth Medical Center and Case Western Reserve UniversityClevelandUSA
  6. 6.University of South Carolina Research FoundationColumbiaUSA
  7. 7.Infectious DiseasesMiriam Hospital and Brown UniversityProvidenceUSA

Personalised recommendations